Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
GRFS · against 223 other Healthcare companies of similar size
Ranked #9 of 224 · scores higher than 95% of peers
Bars: peers in each 10-point band of the valuation score22 peers with a valuation score of 90–100, including GRFS · Click a bar to see the companies
Mainly thanks to its earnings yield and EBITDA yield, which are stronger than most Healthcare peers.
| Metric | GRFS | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 221 reported | 8.8% | 2.5% | 96% | 30% | |
| EBITDA yieldHigher is better · 222 reported | 11.8% | 4.6% | 91% | 50% | |
| Free cash flow yieldHigher is better · 125 reported | Not reported | 1.2% | — | — | 20% |
| Book yieldHigher is better · 223 reported | Not reported | 24.4% | — | — | Context only |
A metric that is not reported is left out of the score; the other weights are rescaled.
| Rank | Company | Market cap | Valuation | Overall |
|---|---|---|---|---|
| 1 | 52.2B HKD (≈$6.7B) | 99 | 56 | |
| 1 | 37.3B HKD (≈$4.8B) | 99 | 90 | |
| 3 | 89.5B HKD (≈$11.5B) | 98 | 67 | |
| 4 | 22.0B CNY (≈$3.1B) | 96 | 67 | |
| 4 | 10.4B USD | 96 | 64 | |
| 7 | 692.7B JPY (≈$4.7B) | 94 | 63 | |
| 7 | 11.6B USD | 94 | 58 | |
| 9 | 1.09T JPY (≈$7.4B) | 93 | 75 | |
| 9 | 488.5B JPY (≈$3.3B) | 93 | 72 | |
| 9 | 5.8B USD | 93 | 64 | |
| 9 | 3.6B GBP (≈$4.7B) | 93 | 64 | |
| 13 | 26.5B CNY (≈$3.7B) | 92 | 69 | |
| 13 | 11.6B USD | 92 | 57 | |
| 15 | 45.1B HKD (≈$5.8B) | 91 | 53 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score